PANCREATIC ADENOSQUAMOUS CARCINOMA
Clinical trials for PANCREATIC ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer patients in global drug trial
Disease control Recruiting nowThis study is testing whether a new drug called daraxonrasib, given alone or with standard chemotherapy, works better than chemotherapy alone for people with advanced pancreatic cancer that has spread. About 900 participants will be randomly assigned to receive one of three treat…
Matched conditions: PANCREATIC ADENOSQUAMOUS CARCINOMA
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Targeted drug trial aims to keep pancreatic cancer from coming back
Disease control Recruiting nowThis study is testing if adding the drug olaparib after surgery and chemotherapy can help prevent pancreatic cancer from returning. It is for patients whose cancer has been surgically removed and who have specific genetic mutations (BRCA1, BRCA2, or PALB2). Participants will take…
Matched conditions: PANCREATIC ADENOSQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC